Patent Assignment
Reel/Frame 048383/0396
Assignment of Assignor's Interest
Recorded: 2019-02-20
Pages: 4
Assignee
QLT INC.
SUITE 101 - 887 GREAT NORTHERN WAY, VANCOUVER, V5T 4T5, CANADA
Covered Property
(1)
Therapeutic Regimen and Methods for Treating or Ameliorating Visual Disorders Associated with an Endogenous Retinoid Deficiency
Application:
15/968,358 →
Publication:
US 2019/0029986
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Feb 20, 2019
From: QLT INC.
To: NOVELION THERAPEUTICS INC.
Reel/Frame 048383/0577 →
Assignment of Assignor's Interest
Feb 21, 2019
From: NOVELION THERAPEUTICS INC.
To: RETINAGENIX, LLC
Reel/Frame 048403/0004 →
Assignment of Assignor's Interest
Mar 20, 2020
From: RETINAGENIX, LLC
To: RETINAGENIX THERAPEUTICS, INC.
Reel/Frame 052175/0176 →
Assignment of Assignor's Interest
Apr 7, 2021
From: RETINAGENIX THERAPEUTICS, INC.
To: RETINAGENIX HOLDINGS LLC
Reel/Frame 055857/0001 →